关注
TUĞBA GÜNGÖR
标题
引用次数
引用次数
年份
Poly (thieno [3, 4-b][1, 4] dioxine) and poly ([1, 4] dioxino [2, 3-c] pyrrole) derivatives: p-and n-dopable redox-active electrode materials for solid state supercapacitor …
D Yiğit, T Güngör, M Güllü
Organic Electronics 14 (12), 3249-3259, 2013
272013
New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects
T Güngör, A Ozleyen, YB Yılmaz, P Siyah, M Ay, S Durdağı, TB Tumer
European Journal of Medicinal Chemistry 221, 113566, 2021
262021
Prodrugs for nitroreductase based cancer therapy-2: Novel amide/Ntr combinations targeting PC3 cancer cells
T Güngör, FC Önder, E Tokay, ÜG Gülhan, N Hacıoğlu, TT Tok, A Çelik, ...
European Journal of Medicinal Chemistry 171, 383-400, 2019
242019
Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in …
E Tokay, T Güngör, N Hacıoğlu, FC Önder, ÜG Gülhan, TT Tok, A Celik, ...
European Journal of Medicinal Chemistry 187, 111937, 2020
172020
Microwave assisted, sequential two-step, one-pot synthesis of novel imidazo [1, 2-a] pyrimidine containing tri/tetrasubstituted imidazole derivatives
T Güngör
Turkish Journal of Chemistry 45 (1), 219-230, 2021
82021
Prodrugs for nitroreductase based cancer therapy-4: Towards prostate cancer targeting: Synthesis of N-heterocyclic nitro prodrugs, Ssap-NtrB enzymatic activation and anticancer …
T Güngör, E Tokay, ÜG Gülhan, N Hacıoğlu, A Çelik, F Köçkar, M Ay
Bioorganic Chemistry 105, 104450, 2020
72020
Synthesis and biological evaluation of 2, 4, 6-trinitroaniline derivatives as potent antitumor agents
N Hacıoğlu, T Güngör, E Tokay, FC Önder, M Ay, F Köçkar
Monatshefte für Chemie-Chemical Monthly 151, 1629-1641, 2020
62020
Electrochemical behavior and voltammetric determination of some nitro-substituted benzamide compounds
Ö SAĞLAM, FC ÖNDER, T Güngör, M Ay, Y Dilgin
Turkish Journal of Chemistry 42 (3), 780-793, 2018
62018
Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen
A Çelik, G Yetiş, M Ay, T Güngör
Bioorganic & Medicinal Chemistry Letters 26 (16), 4057-4060, 2016
62016
Carbon nanofiber/poly (tetrahydro [1, 4] dioxino [2, 3-b] thieno [3, 4-e][1, 4] dioxine) binder-free composite redox-active electrode for electrochemical energy storage …
D Yiğit, F Soysal, T Güngör, B Çiçek, M Güllü
RSC advances 7 (66), 41419-41428, 2017
52017
One pot, multicomponent protocol for the synthesis of novel imidazo[1,2-a]pyrimidine-based pyran analogs: a potential biological scaffold
T Güngör
Monatshefte für Chemie-Chemical Monthly 151, 781-789, 2020
42020
Preparation of novel imidazo [1, 2-a] pyrimidine derived schiff bases at conventional and microwave heating conditions
T Güngör
Balıkesir Üniversitesi Fen Bilimleri Enstitüsü Dergisi 22 (2), 428-438, 2020
32020
Prodrugs for Nitroreductase Based Cancer Therapy‐5: Development of Trinitroaniline Prodrugs/Ssap‐NtrB Combinations for Liver Cancer Using Intracellular and Extracellular Conditions
N Hacıoğlu, T Güngör, E Tokay, ÜG Gülhan, A Çelik, M Ay, F Köçkar
ChemistrySelect 6 (25), 6315-6323, 2021
22021
Synthesis of SMZ derivatives and investigation of effects on germination, root, and plant growth of\textit {Arabidopsis thaliana} L.
T GÜNGÖR, FC ÖNDER, F Sezer, A ÖZBİLEN, KM TAŞKIN, M Ay
Turkish Journal of Chemistry 43 (4), 1123-1133, 2019
22019
Synthesis of new imine-/amine-bearing imidazo [1, 2-a] pyrimidine derivatives and screening of their cytotoxic activity
T Güngör, HN ATALAY, YB Yilmaz, T Tümer, M Ay
Turkish Journal of Chemistry 47 (5), 1064-1074, 2023
2023
Synthesis, Spectroscopic Characterization, Crystal Structure and Theoretical Studies on New Organic Single Crystal of 1-(3, 5-Difluorophenyl)-3-(2-Nitrophenyl) Urea
T Güngör, T Karakurt, ZS Şahin
Celal Bayar University Journal of Science 17 (3), 285-295, 2021
2021
Nitroreductases in Prodrug Therapies
T Güngör, FC Önder, M Ay
Recent Advancement in Prodrugs, 227-252, 2020
2020
Nitroredüktaz esaslı kanser tedavisine yönelik aromatik ve heterosiklik ilaç-öncü bileşiklerin geliştirilmesi
T Güngör
Fen Bilimleri Enstitüsü, 2016
2016
Kanser Terapilerinde Kullanılmak Üzere Ssap-NtrB/İlaç-Öncü (Prodrug) Bileşik BirleşimininAraştırılması
G Yetiş, A Çelik, M Ay, T Güngör, F Cömert, MT Yavaşoğlu
Enzim Prodrug Terapi: Nitroredüktazlar ile İlaç Öncü Bileşiklerin Aktivasyonu
A Çelik, G Yetiş, M Ay, T Güngör, F Cömert
系统目前无法执行此操作,请稍后再试。
文章 1–20